Sponsored Research Grants

.................................................................................................................................................................................................

Title: Development of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells.

Funding Agency: VI–D&P/623/2018-19/TDT DPRP/DST.

Amount (INR): 1,41,00,000.

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad & Dr.A.Ramesh.

Status: Sanctioned.

...........................................................................................................................................................................................................

Title: Spirnula Biomass Cultivation, isolations of chemical constitutes and commercial exploration.

Funding Agency: SEED/SCSP/2019/80

Amount (INR): 77,86,202.

Duration: 3 Years.

PI/Co-PI: Dr.Vanitha & Dr.D.Santosha

Status: Ongoing.

...........................................................................................................................................................................................................

Title: Development and characterization of polymer based letrozole loaded na no particulate formulation to induce programmed cellular death in breast cancer,in vitro and invivo studies.

Funding Agency: ICMR, 3-2-217/2019

Amount (INR): 13,67,000.

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad & Mrs M.Sandhya.

Status: Ongoing.

........................................................................................................................................................................................................... 

Title: In-silico optimization and synthesis of novel andragrapholade analogues as PI3K Inhibitors.

Funding Agency: ICMR, 3-2-2-56/2019

Amount (INR): 13,67,000.

Duration: 3 Years.

PI/Co-PI: Y.Viswanadham.

Status: Ongoing.

........................................................................................................................................................................................................... 

Title: Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study.

Funding Agency: DBT, [6242-P55/RGCB/PBD/DBT,APDK/2015]

Amount (INR): 24,75,480.

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad

Status: Completed.

...........................................................................................................................................................................................................

Title: Binding kinetics & Interaction analysis of Pertuzumab in complex with isolated extracellular domain II (sHER2 dII) & domain IV (sHER2 dIV) of (sHER2): Structural Implications in the inhibition of HER2/HER3 mediated dimerization and activation.

Funding Agency: SERB, [YSS/2014/002005].

Amount (INR): 27,90,000

Duration: 3 Years.

PI/Co-PI: Dr.Dokala.A

Status: Completed.

........................................................................................................................................................................................................... 

 Title: Projects under Institute - Industry Innovation Cell (IIIC).

Funding Agency: MSME (FMC)

Amount (INR): 3,29,000

Duration: 3 Years.

PI/Co-PI: Dr.Ramesh & Mr.P.Prabakar

Status: Completed.

........................................................................................................................................................................................................... 

Title: Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats.

Funding Agency: DST, SR/WOS-A/LS-491/2012

Amount (INR): 21,00,000

Duration: 3 Years.

PI/Co-PI: Dr.D.Santosha

Status: Completed.

...........................................................................................................................................................................................................

Title: Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

Funding Agency: DST, SR/WOS-A/CS-77/2012

Amount (INR): 22,50,000

Duration: 3 Years.

PI/Co-PI: Mrs S.Sandhyarani

Status: Completed.

...........................................................................................................................................................................................................

Title Optimization and evaluation of prazosin floating microspheres using response surface methodology

Funding Agency: DST, SR/WOS-A/LS-496/2012

Amount (INR): 21,20,000

Duration: 3 Years.

PI/Co-PI: Dr.K.Vanitha

Status: Completed.

...........................................................................................................................................................................................................

Title Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).

Funding Agency: DST, SR/CSI/107/2012(G)

Amount (INR): 48,20,000

Duration: 3 Years.

PI/Co-PI: Dr.A.Ramesh

Status: Completed.

...........................................................................................................................................................................................................

Title Travel Grant sanctioned to present research paper in FEBS  EMBO-14 30 Aug - 4 Sep 2014 in PARIS, FRANCE.

Funding Agency: DST, [SERB/F/7397/2014-15]

Amount (INR): 1,35,000

Duration: 1 Years.

PI/Co-PI: Mr.G.Deepak Reddy

Status: Completed.

........................................................................................................................................................................................................... 

Title: Travel Grant sanctioned to present research paper in the GTC conference “Protein Kinases and Drug Design” BOSTON, USA on 08-10th Nov, 2012.

Funding Agency: DST, [SR/ITS/3737/2012-13]

Amount (INR): 1,37,580.

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad

Status: Completed.

........................................................................................................................................................................................................... 

Title: Mechanistic Studies: Acridones as reverters of multidrug resistance (MDR) in cancer

Funding Agency: AICTE, [1-51/RIFD/CA/11/2011-12]

Amount (INR): 9,00,000

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad

Status: Completed.

........................................................................................................................................................................................................... 

Title: Design and Synthesis of nitric oxide donating phenoxazine derivatives as reverters of multidrug resistance (MDR) in cancer.

Funding Agency: SERB, [SR/FT/LS-75/2009]

Amount (INR): 18,02,000

Duration: 3 Years.

PI/Co-PI: Dr.V.V.S.Rajendra Prasad

Status: Completed.

...........................................................................................................................................................................................................


Print   Email